Guanhao Biotech Co.,Ltd. (300238.SZ)
CNY 13.98
(-1.48%)
CNY 13.98
(-1.48%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 201.68 Million CNY | -15.73% |
| 2022 | 239.32 Million CNY | -31.73% |
| 2021 | 350.57 Million CNY | -16.14% |
| 2020 | 418.06 Million CNY | -6.1% |
| 2019 | 445.21 Million CNY | -7.93% |
| 2018 | 483.57 Million CNY | -4.29% |
| 2017 | 505.24 Million CNY | 118.79% |
| 2016 | 230.93 Million CNY | 23.89% |
| 2015 | 186.4 Million CNY | 112.01% |
| 2014 | 87.92 Million CNY | 18.24% |
| 2013 | 74.36 Million CNY | -15.39% |
| 2012 | 87.88 Million CNY | 38.9% |
| 2011 | 63.27 Million CNY | -30.49% |
| 2010 | 91.02 Million CNY | 100.75% |
| 2009 | 45.34 Million CNY | 82.78% |
| 2008 | 24.8 Million CNY | 23.85% |
| 2007 | 20.03 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 208.81 Million CNY | -5.39% |
| 2024 Q1 | 220.71 Million CNY | 9.43% |
| 2024 Q3 | 259.24 Million CNY | 24.15% |
| 2023 Q1 | 236.98 Million CNY | -0.98% |
| 2023 FY | 201.68 Million CNY | -15.73% |
| 2023 Q2 | 220.45 Million CNY | -6.97% |
| 2023 Q3 | 208.74 Million CNY | -5.31% |
| 2023 Q4 | 201.68 Million CNY | -3.38% |
| 2022 FY | 239.32 Million CNY | -31.73% |
| 2022 Q3 | 281.77 Million CNY | -2.78% |
| 2022 Q4 | 239.32 Million CNY | -15.06% |
| 2022 Q2 | 289.83 Million CNY | -14.52% |
| 2022 Q1 | 339.06 Million CNY | -3.28% |
| 2021 FY | 350.57 Million CNY | -16.14% |
| 2021 Q4 | 350.57 Million CNY | -5.97% |
| 2021 Q1 | 388.67 Million CNY | -7.03% |
| 2021 Q2 | 410.85 Million CNY | 5.71% |
| 2021 Q3 | 372.84 Million CNY | -9.25% |
| 2020 Q1 | 457.89 Million CNY | 2.85% |
| 2020 Q2 | 445.84 Million CNY | -2.63% |
| 2020 Q4 | 418.06 Million CNY | -29.13% |
| 2020 Q3 | 589.89 Million CNY | 32.31% |
| 2020 FY | 418.06 Million CNY | -6.1% |
| 2019 Q2 | 437.81 Million CNY | -5.95% |
| 2019 Q1 | 465.54 Million CNY | -3.73% |
| 2019 FY | 445.21 Million CNY | -7.93% |
| 2019 Q4 | 445.21 Million CNY | 3.97% |
| 2019 Q3 | 428.22 Million CNY | -2.19% |
| 2018 Q1 | 485.11 Million CNY | -3.98% |
| 2018 FY | 483.57 Million CNY | -4.29% |
| 2018 Q4 | 483.57 Million CNY | -12.69% |
| 2018 Q3 | 553.84 Million CNY | -5.38% |
| 2018 Q2 | 585.32 Million CNY | 20.66% |
| 2017 Q4 | 505.24 Million CNY | 174.18% |
| 2017 FY | 505.24 Million CNY | 118.79% |
| 2017 Q3 | 184.27 Million CNY | 6.99% |
| 2017 Q2 | 172.23 Million CNY | 6.89% |
| 2017 Q1 | 161.12 Million CNY | -30.23% |
| 2016 FY | 230.93 Million CNY | 23.89% |
| 2016 Q4 | 230.93 Million CNY | -28.38% |
| 2016 Q2 | 299.12 Million CNY | 56.72% |
| 2016 Q3 | 322.43 Million CNY | 7.79% |
| 2016 Q1 | 190.86 Million CNY | 2.39% |
| 2015 FY | 186.4 Million CNY | 112.01% |
| 2015 Q3 | 123.21 Million CNY | 45.99% |
| 2015 Q2 | 84.4 Million CNY | 7.24% |
| 2015 Q4 | 186.4 Million CNY | 51.28% |
| 2015 Q1 | 78.7 Million CNY | -10.49% |
| 2014 FY | 87.92 Million CNY | 18.24% |
| 2014 Q4 | 87.92 Million CNY | 23.26% |
| 2014 Q1 | 66.74 Million CNY | -10.25% |
| 2014 Q2 | 61.74 Million CNY | -7.49% |
| 2014 Q3 | 71.33 Million CNY | 15.53% |
| 2013 Q1 | 76.06 Million CNY | -13.44% |
| 2013 Q4 | 74.36 Million CNY | 1.35% |
| 2013 Q3 | 73.37 Million CNY | -3.9% |
| 2013 Q2 | 76.34 Million CNY | 0.37% |
| 2013 FY | 74.36 Million CNY | -15.39% |
| 2012 Q4 | 87.88 Million CNY | -13.74% |
| 2012 Q1 | 79.22 Million CNY | 25.22% |
| 2012 Q2 | 87.71 Million CNY | 10.71% |
| 2012 FY | 87.88 Million CNY | 38.9% |
| 2012 Q3 | 101.87 Million CNY | 16.15% |
| 2011 Q3 | 73.09 Million CNY | -21.6% |
| 2011 Q2 | 93.22 Million CNY | 8.2% |
| 2011 Q1 | 86.16 Million CNY | -5.34% |
| 2011 Q4 | 63.27 Million CNY | -13.44% |
| 2011 FY | 63.27 Million CNY | -30.49% |
| 2010 FY | 91.02 Million CNY | 100.75% |
| 2010 Q4 | 91.02 Million CNY | 0.0% |
| 2009 FY | 45.34 Million CNY | 82.78% |
| 2008 FY | 24.8 Million CNY | 23.85% |
| 2007 FY | 20.03 Million CNY | 0.0% |